The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Review Glioblastoma multiforme – an overview
Open accessAbstract
Glioblastoma multiforme is a central nervous system tumor of grade IV histological malignancy according to the WHO classification. Over 90% of diagnosed glioblastomas multiforme cases are primary gliomas, arising from normal glial cells through multistep oncogenesis. The remaining 10% are secondary gliomas originating from tumors of lower grade. These tumors expand distinctly more slowly. Although genetic alterations and deregulations of molecular pathways leading to both primary and secondary glioblastomas formation differ, morphologically they do not reveal any significant differences. Glioblastoma is a neoplasm that occurs spontaneously, although familial gliomas have also been noted. Caucasians, especially those living in industrial areas, have a higher incidence of glioblastoma. Cases of glioblastoma in infants and children are also reported. The participation of sex hormones and viruses in its oncogenesis was also suggested. Progression of glioblastoma multiforme is associated with deregulation of checkpoint G1/S of a cell cycle and occurrence of multiple genetic abnormalities of tumor cells. Metastases of glioblastoma multiforme are rarely described. Treatment of glioblastoma multiforme includes tumor resection, as well as radiotherapy and chemotherapy. Drugs inhibiting integrin signaling pathways and immunotherapy are also employed. Treatment modalities and prognosis depend on the tumor localization, degree of its malignancy, genetic profile, proliferation activity, patient's age and the Karnofsky performance scale score. Although the biology of glioblastoma multiforme has recently been widely investigated, the studies summarizing the knowledge of its development and treatment are still not sufficient in terms of comprehensive brain tumor analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., & Byhardt, R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,544
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Curran, W. J., Scott, C. B., Horton, J., Nelson, J. S., Weinstein, A. S., Fischbach, A. J., Chang, C. H., Rotman, M., Asbell, S. O., Krisch, R. E., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.9.704 · Cited by 1,310
Epidemiology and etiology of gliomas
Ohgaki, H., & Kleihues, P. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0991-y · Cited by 1,252
Epidemiology and molecular pathology of glioma
Schwartzbaum, J. A., Fisher, J. L., Aldape, K. D., & Wrensch, M. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0289 · Cited by 949
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 887
Epidemiology of primary brain tumors: Current concepts and review of the literature
Wrensch, M., Minn, Y., Chew, T., Bondy, M., & Berger, M. S. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.4.278 · Cited by 837
Human cytomegalovirus infection and expression in human malignant glioma.
Cobbs, C., Harkins, L. E., Samanta, M., Gillespie, G. Y., Bharara, S., King, P. H., Nabors, B., Cobbs, C. G., & Britt, W. J. (2002) · PubMed · Cited by 717
Primary and secondary glioblastomas: From concept to clinical diagnosis
Kleihues, P., & Ohgaki, H. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.44 · Cited by 586
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
KOMOTAR, R. J., WILSON, D. A., & CONNOLLY, E. S. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.1.n7a · Cited by 570
Simpson, J. R., Horton, J., Scott, C., Curran, W. J., Rubin, P., Fischbach, J., Isaacson, S., Rotman, M., Asbell, S. O., Nelson, J. S., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90203-8 · Cited by 535
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
Verma, A. (2006) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)70328-4 · Cited by 452
Histopathology, classification, and grading of gliomas
Kleihues, P., Soylemezoglu, F., Schäuble, B., Scheithauer, B. W., & Burger, P. C. (1995) · Glia · doi:10.1002/glia.440150303 · Cited by 356
Zuccoli, G., Marcello, N., Pisanello, A., Servadei, F., Vaccaro, S., Mukherjee, P., & Seyfried, T. N. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-33 · Cited by 267
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Uhm, J. (2009) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(09)79089-1 · Cited by 239
The natural history of extracranial metastasis from glioblastoma multiforme
Lun, M., Lok, E., Gautam, S., Wu, E., & Wong, E. T. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0575-8 · Cited by 223
Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups
Tso, C.-L., Freije, W. A., Day, A., Chen, Z., Merriman, B., Perlina, A., Lee, Y., Dia, E. Q., Yoshimoto, K., Mischel, P. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0077 · Cited by 221
Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort
Collaborators, F. T. M. W. S., Benson, V. S., Pirie, K., Green, J., Casabonne, D., & Beral, V (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604445 · Cited by 199
Pathology and Genetics of Tumours of the Nervous System
McComb, R. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.749-a · Cited by 190
Role of glial filaments in cells and tumors of glial origin: a review
Rutka, J. T., Murakami, M., Dirks, P. B., Hubbard, S. L., Becker, L. E., Fukuyama, K., Jung, S., Tsugu, A., & Matsuzawa, K. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.87.3.0420 · Cited by 176
Cho, D.-Y., Yang, W.-K., Lee, H.-C., Hsu, D.-M., Lin, H.-L., Lin, S.-Z., Chen, C.-C., Harn, H.-J., Liu, C.-L., Lee, W.-Y., et al. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2011.08.020 · Cited by 166
Bevacizumab for the Treatment of Recurrent Glioblastoma
Chamberlain, M. C. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7232 · Cited by 153
Different angiogenic phenotypes in primary and secondary glioblastomas
Karcher, S., Steiner, H. H., Ahmadi, R., Zoubaa, S., Vasvari, G. P., Bauer, H., Unterberg, A. W., & Herold‐Mende, C. C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21648 · Cited by 145
Do Steroid Hormones Play a Role in the Etiology of Glioma?
Kabat, G. C., Etgen, A. M., & Rohan, T. E. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0658 · Cited by 140
Gene Therapy and Targeted Toxins for Glioma
King, G. D., Curtin, J. F., Candolfi, M., Kroeger, K. M., Lowenstein, P. R., & Castro, M. G. (2005) · Current Gene Therapy · doi:10.2174/156652305774964631 · Cited by 122
Estimation and projections of cancer prevalence from cancer registry data
Verdecchia, A., Angelis, G. D., & Capocaccia, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1304 · Cited by 120
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang, J. E., Khuntia, D., Robins, H. I., & Mehta, M. P. (2007) · PubMed · Cited by 112
Biological Mechanisms of Glioma Invasion and Potential Therapeutic Targets
Tysnes, B. B., & Mahesparan, R. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012249216117 · Cited by 103
GFAP: Functional implications gleaned from studies of genetically engineered mice
Messing, A., & Brenner, M. (2003) · Glia · doi:10.1002/glia.10219 · Cited by 97
Age and Radiation Response in Glioblastoma Multiforme
Barker, F. G., Chang, S. M., Larson, D. A., Sneed, P. K., Wara, W. M., Wilson, C. B., & Prados, M. D. (2001) · Neurosurgery · doi:10.1097/00006123-200112000-00002 · Cited by 92
Primary and secondary glioblastomas: From concept to clinical diagnosis
Kleihues, P. (1999) · Neuro-Oncology · doi:10.1215/15228517-1-1-44 · Cited by 91
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
Li, M., Mukasa, A., Inda, M. D. M., Zhang, J., Chin, L., Cavenee, W. K., & Furnari, F. B. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111102 · Cited by 90
Gene Therapy and Targeted Toxins for Glioma
Castro, M. G., Candolfi, M., Kroeger, K. M., King, G. D., Curtin, J. F., Yagiz, K., Mineharu, Y., Assi, H. H., Wibowo, M., Muhammad, A. K. M. G., et al. (2011) · Current Gene Therapy · doi:10.2174/156652311795684722 · Cited by 86
NHERF-1: Modulator of Glioblastoma Cell Migration and Invasion
Kislin, K. L., McDonough, W. S., Eschbacher, J. M., Armstrong, B. A., & Berens, M. E. (2009) · Neoplasia · doi:10.1593/neo.81572 · Cited by 79
Antiangiogenic Therapy for Glioblastoma
Gerstner, E. R., & Batchelor, T. T. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182431c6f · Cited by 79
Lymph node metastases from glioblastoma multiforme.
Wallace, C. J., Forsyth, P. A., & Edwards, D. R. (1997) · PubMed · Cited by 71
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β‐tubulin
Katsetos, C. D., Dráberová, E., Legido, A., Dumontet, C., & Dráber, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21870 · Cited by 68
Schr�der, R., Bien, K., Kott, R., Meyers, I., & V�ssing, R. (1991) · Acta Neuropathologica · doi:10.1007/bf00296550 · Cited by 66
Expression of p19 INK4d, CDK4, CDK6 in glioblastoma multiforme
Ng, H. (2000) · British Journal of Neurosurgery · doi:10.1080/02688690042870 · Cited by 65
Rogers, A., Le, J., Sather, S., Pernu, B. M., Graham, D. K., Pierce, A. M., & Keating, A. K. (2011) · Oncogene · doi:10.1038/onc.2011.588 · Cited by 64
Wilhelmsson, U., Eliasson, C., Bjerkvig, R., & Pekny, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206372 · Cited by 63
GFAP Gene Expression during Development of Astrocyte
Baba, H., Nakahira, K., Morita, N., Tanaka, F., Akita, H., & Ikenaka, K. (1997) · Developmental Neuroscience · doi:10.1159/000111185 · Cited by 63
Suh, S., LeBlanc, T. W., Shelby, R. A., Samsa, G. P., & Abernethy, A. P. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000434 · Cited by 61
Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis
Cobbs, C. (2011) · Herpesviridae · doi:10.1186/2042-4280-2-10 · Cited by 59
Glioblastoma multiforme: a rare manifestation of extensive liver and bone metastases
Robert, M. E., & Wastie, M. L. (2008) · Biomedical Imaging and Intervention Journal · doi:10.2349/biij.4.1.e3 · Cited by 54
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. γ‐tubulin
Katsetos, C. D., Dráberová, E., Legido, A., & Dráber, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21884 · Cited by 53
Butterfly glioma of the corpus callosum
Agrawal, A. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.48769 · Cited by 42
RNA interference therapy for glioblastoma
Guo, D., Wang, B., Han, F., & Lei, T. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.481667 · Cited by 35
Estradiol induces JNK-dependent apoptosis in glioblastoma cells
Altıok, N., Ersöz, M., & Koyutürk, M. (2011) · Oncology Letters · doi:10.3892/ol.2011.385 · Cited by 30
AL‐RIKABI, A. C., Al-Sohaibani, M. O., Jamjoom, A. B., et al. (1997) · Cytopathology · doi:10.1111/j.1365-2303.1997.tb00573.x · Cited by 26
Occupational and environmental risk factors for brain cancer: a pilot case-control study in France
Spinelli, V., Chinot, O. L., Cabaniols, C., Giorgi, R., Alla, P., & Lehucher‐Michel, M. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.06.020 · Cited by 24
Rickert, C. H., Riemenschneider, M. J., Schachenmayr, W., Richter, H., Bockhorn, J., Reifenberger, G., & Paulus, W. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00199.x · Cited by 23
Bevacizumab in glioblastoma multiforme
Specenier, P. M. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.179 · Cited by 22
Role of glial filaments in cells and tumors of glial origin: a review
Rutka, J. T., Murakami, M., Dirks, P. B., Hubbard, S. L., Becker, L. E., Fukuyama, K., Jung, S., & Matsuzawa, K. (1997) · Neurosurgical FOCUS · doi:10.3171/foc.1997.3.1.2 · Cited by 8
Cited by
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Mun, E. J., Babiker, H. M., Weinberg, U., Kirson, E. D., & Von Hoff, D. D. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1117 · Cited by 380
Chen, P.-H., Cheng, C.-H., Shih, C.-M., Ho, K.-H., Lin, C.-W., Lee, C.-C., Liu, A.-J., Chang, C.-K., & Chen, K.-C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167096 · Cited by 41
Delbaz, A., Chen, M., Jen, F. E.-C., Schulz, B. L., Gorse, A.-D., Jennings, M. P., St John, J. A., & Ekberg, J. A. K. (2020) · Infection and Immunity · doi:10.1128/iai.00955-19 · Cited by 18
Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides
Achimba, F., Faezov, B., Cohen, B., Dunbrack, R., & Holford, M. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0256 · Cited by 6
Metadata
- Authors
- Urbańska, K., Sokołowska, J., Szmidt, M., & Sysa, P.
- Venue
- Współczesna Onkologia
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2014
- Volume
- 5
- Issue
- 5
- Pages
- 307-312
- ISSN
- 1428-2526 (ISSN-L)
- OpenAlex
- W2143432704
- Cited by
- 276
- References
- 59
- FWCI
- 4.35
- Type
- journal article
- Language
- pl
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.